Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity

被引：1

作者：

Dupuis, Josephine ^{[1
]}

Tauber, Marie ^{[2
,3
]}

Mahe, Emmanuel ^{[4
]}

Jachiet, Marie ^{[5
]}

Soria, Angele ^{[6
]}

Tetart, Florence ^{[7
]}

Puzenat, Eve ^{[8
]}

Pasteur, Justine ^{[9
]}

Raison-Peyron, Nadia ^{[10
]}

Giordano-Labadie, Francoise ^{[11
]}

Droitcourt, Catherine ^{[12
]}

Leleu, Camille ^{[13
]}

Nosbaum, Audrey ^{[3
]}

Aubert, Helene ^{[14
]}

Moigne, Marie L. E. ^{[14
]}

Bernier, Claire ^{[14
]}

Barbarot, Sebastien ^{[15
]}

Ezzedine, Khaled ^{[16
]}

Diaz, Emmanuelle ^{[16
]}

Hubiche, Thomas ^{[17
]}

Faiz, Sarah ^{[18
]}

Azib, Selma ^{[1
]}

Dezoteux, Frederic ^{[1
,19
]}

Chosidow, Olivier ^{[20
]}

Staumont-Salle, Delphine ^{[1
,19
]}

机构：

[1] CHU Lille, Serv Dermatol, F-59037 Lille, France

[2] CHU Toulouse, Hop Larrey, Serv Dermatol, Toulouse, France

[3] Hop Lyon Sud, Allergol & Immunol Clin, CIRI Inserm U1111, Lyon, France

[4] Hop Victor Dupouy, Serv Dermatol, Argenteuil, France

[5] Hop St Louis, Dermatol, AP HP, Paris, France

[6] Hop Tenon, AP HP, Dermatol & Allergol, Paris, France

[7] CHU Rouen, Dermatol, Rouen, France

[8] CHU Besancon, Dermatol, Besancon, France

[9] CHU Clermont Ferrand, Dermatol, Clermont Ferrand, France

[10] CHU Montpellier, Dermatol, Montpellier, France

[11] CHU Toulouse, Dermatol, Toulouse, France

[12] Univ Rennes, Irset Inst Rech Sante, Dept Dermatol, CHU Rennes,Inserm,EHESP,UMR S 1085, Rennes, France

[13] Hop Bocage, Dermatol, Dijon, France

[14] CHU Nantes, Dermatol, Nantes, France

[15] Nantes Univ, Dept Dermatol, CHU Nantes, INRAE,UMR 1280,PhAN, Nantes, France

[16] Hop Henri Mondor, AP HP, Dermatol, Creteil, France

[17] Hop Archet 2, Dermatol, Nice, France

[18] CH Douai, Dermatol, Douai, France

[19] Univ Lille, Lille Inflammat Translat Res Inst INFINITE, INSERM U1286, Lille, France

[20] Univ Hosp La Pitie Salpetriere, AP HP, Facial Dermatosis Clin, Paris, France

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2025年 / 39卷 / 02期

关键词：

D O I：

10.1111/jdv.20264

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：e174 / e178

页数：5

共 50 条

[21] Clinically meaningful responses in moderate-to-severe atopic dermatitis patients treated with Dupilumab
de Bruin-Weller, M.
Eckert, L.
Simpson, E. L.
Cork, M. J.
Ardeleanu, M.
Chen, Z.
Shumel, B.
Rossi, A. B.
Graham, N. M. H.
Pirozzi, G.
Gadkari, A.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 116 - 116
[22] DUPILUMAB DEMONSTRATES CONSISTENT EFFICACY ACROSS RACIAL SUBGROUPS IN PEDIATRIC PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
Alexis, Andrew
Desai, Seemal R.
Rice, Zakiya
Heath, Candrice
Zhang, Haixin
Khokhar, Faisal A.
Marco, Ainara Rodriguez
Shah, Parul
ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 44 - 44
[23] Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis
Devjani, Shivali
Engel, Priya, V
Javadi, Sogol S.
Smith, Brandon
Wu, Jashin J.
LANCET, 2023, 402 (10415): : 1833 - 1834
[24] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
Parker, Jennifer J.
Sugarman, Jeffrey L.
Silverberg, Nanette B.
Gonzalez, Mercedes Elena
Ramien, Michele L.
Teng, Joyce M. C.
Paller, Amy S.
PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505
[25] Switching from dupilumab to abrocitinib in patients with moderate-to-severe atopic dermatitis: an analysis of responders and nonresponders to dupilumab
Silverberg, Jonathan, I
Simpson, Eric L.
Thyssen, Jacob P.
Pink, Andrew E.
Weidinger, Stephan
Chan, Gary
Lazariciu, Irina
Clibborn, Claire
Guler, Erman
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[26] Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients
Achten, Roselie
Thijs, Judith
van Luijk, Chantal
Knol, Edward
Delemarre, Eveline
de Graaf, Marlies
Bakker, Daphne
de Boer, Joke
van Wijk, Femke
de Bruin-Weller, Marjolein
CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (02): : 239 - 243
[27] Long-term safety and efficacy of open-label dupilumab in patients with moderate-to-severe atopic dermatitis
Deleuran, M.
Thaci, D.
Beck, L.
Forman, S.
Soong, W.
Hussain, I.
Bissonnette, R.
Bouaziz, J.
Gelfand, J.
Lawrence, S.
Chen, Z.
Akinlade, B.
Gadkari, A.
Eckert, L.
Graham, N.
Ardeleanu, M.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 34 - 34
[28] Long-Term Safety and Efficacy of Open-Label Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
Deleuran, Mette
Thaci, Diamant
Beck, Lisa A.
Forman, Seth
Soong, Weily
Hussain, Iftikhar
Bissonnette, Robert
Bouaziz, Jean-David
Gelfand, Joel
Sher, Lawrence
Chen, Zhen
Akinlade, Bolanle
Gadkari, Abhijit
Eckert, Laurent
Graham, Neil M. H.
Pirozzi, Gianluca
Ardeleanu, Marius
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB381 - AB381
[29] Comparison of Efficacy of Baricitinib and Dupilumab in the Treatment of Chinese Moderate-To-Severe Atopic Dermatitis: A Retrospective Study
Liu, Bo
Song, Xiaoting
Liao, Shuanglu
Luan, Tingting
Zhao, Zuotao
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (10) : 966 - 974
[30] Does Monthly Dupilumab Therapy Maintain its Clinical Efficacy in Moderate-to-Severe Atopic Dermatitis?
Kim, Su Min
Park, Chang Ook
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (05) : 681 - 683

← 1 2 3 4 5 →